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The Faculty Senate meeting was called to order at 3:35 p.m. on September 1O, 1996, in
the Kiva. Senate President Beulah Woodfin presided.

Senators present: Margery Amdur (Art & Art History), Steven Block (Music), Alok
Bohara (Economics), James Boone (Anthropology), Jane Bruker (Gallup), William Buss
{Pharmacology), Helen Damico (English), Victor Delclos (Individual Family &
Community Education), Michelle Diel (Valencia), Ernest Dole (Pharmacy) , Gregory
Franchini (Psychiatry), John Gahl (Electrical & Computer Engineering), Deborah
Graham (Health Sciences Library), Jaime Grinberg (Education), Thomas Hagstrom
{Mathematics & Statistics), William Johnson (Biology), Christiane Joost-Gaugier (Art &
Art History), Peggy Kelley (Surgery) , Craig Kelsey (Physical Performance &
Development), Larry Lavender (Theatre & Dance), George Luger (Computer Science),
Neeraj Magotra (Electrical & Computer Engineering), Wanda Martin (Engl ish), Christine
Nathe (Dental Hygiene), Donald Neaman (Electrical & Computer Engineering),
Elizabeth Nielsen (Education Specialities), Eric Nuttal (Chemical & Nuclear
Engineering, Philip Reyes (Biochemistry), Mario Rivera (Public Administration),
Stephanie Ruby (Cell Biology), Christine Sauer (Economics), Loretta Serna (Education
S~ecialities), Avarham Shama (Anderson Schools of Management), Scott Taylor (Law),
Nicole Touchet (Family & Community Medicine), Mete Turan (Architecture & Planning),
Pauline Turner (Individual, Family, and Community Education), Carolyn Voss
{Medicine), Holly Waldron (Psychology), Paul Weiss (General Library), Sherman
~ilcox (Linguistics), Beulah Woodfin (Biochemistry), Melvin Yazawa (H istory), Nancy
Z_1egler (Gallup), and Harry Llull, ex-officio Senate Operations member, (General
Library)
Senators absent: William Dail (Anatomy), Tom Decoster (Orthopaedics), Patrick
Gallacher (English), Peter Pabisch (Foreign Languages & Literatures) , Richard Reid
{Anderson Schools of Management), Gloria Sarto (Obstretics & Gynecolo~y), Sandra
Schwanberg (Nursing), Russell Snyder (Neurology), Joseph Spaeth (Radiology)
Senators excused: Laura Crossey (Earth & Planetary Sciences), .Diane Dotts (Gall~p),
John Geissman (Earth & Planetary Sciences), Jonathan Porter (History), Gerald Weiss
{Physiology)

1. APPROVAL OF AGENDA
Initially, the agenda was approved as presented. Later in the meeting, agenda
item #8 was amended to read " . .. Research Fraud Pol icy'' instead of "... Research
Policy Fraud."
1
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2. APPROVAL OF SUMMARIZED MINUTES (May 7, 1996}
The summarized minutes for the May 7, 1996 Election of Officers, and May 7, 1996
Last Meeting of 1995-96 Senate were approved as presented.

3. MEMORIAL MINUTE FOR PROFESSOR EMERITUS ARCHIE J. BAHM
The Memorial Minute for Professor Emeritus Archie J. Bahm was read by Professor
Fred Sturm. The minute was adopted by the Senate. Professor Sturm asked the
University Secretary to send copies of the Memorial Minute to the family of Archie
Bahm.

Archie John Bahm (1907-1996)
Colleagues of Archie Bahm know that he was committed to open dialogue and
discussion concerning issues of philosophy and social concern. He viewed his
teaching, research, and publications as ways of accomplishing this.
He was born 21 August 1907 in Imlay, Michigan. Formal education included the
AB. from Albion College, with election to Phi Beta Kappa and Phi Kappa Phi, and
both the M.A. and Ph.D. from the University of Michigan in 1930 and 1933.
He taught at Texas Tech (1934-1946), the University of Denver (1946-1948), and
the University of New Mexico from 1948 until his retirement in 1973.
Throughout his teaching career he sought means of bringing philosophers together
for dialogue, and of fostering interdisciplinary discussion. He was instrumental in
founding the New Mexico/West Texas Philosophical Society, the Mountain-Plains
Philosophical Association, and the University of New Mexico "21 Club".
World peace, and an accompanying global philosophy, were his passions: He
travelled extensively up to the end of his life participating in ~arid ~nd regional
congresses of philosophy. His continuing correspondenc~ with ph1l~sophers
world-wide was voluminous. Fulbright Research Fellowships took him to the
University of Rangoon (1955-56) and Banaras Hindi University (1962-63).
Author of 22 books several of which have been translated into other languages,
he published many' articles in professional journals he~e and abroa~. Recently .
these were contributions in the field of systems analysis. The American Humarns.t
Association named him "Humanist of the Year'', and the J!angsu Academy of s.oc1al
Sciences together with the University of Nanjing re~ently inaugurated the Archie J.
Bahm Institute for Comparative Philosophical Studies.
When he learned he had terminal cancer he worked with great intensity writing
2
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_........ ...
what h~ knew was t~ be his final book. The manuscript was completed, but his last
words Just before dying were instructions for revisions to the final chapter.
4. PROVOST'S COMMENTS
Provost William Gordon provided information on pressing issues discussed at
previous Senate meetings and an update on initiatives undertaken since then:
•
The Research Services Office (formerly Office of Research Administration)
has been reorgan ized into divisions in order to provide more efficient services
to faculty in the areas of Contracts and Policy; Contracts and Information
Services; Outreach Services; and Lab/Industry Relations.
•
The Associate Provost for Research is conducting an analysis of how
research overhead funding has been spent and evaluating it against actual
needs. This will result in a comprehensive budget plan for the upcoming year.
•
An Associate Dean of Graduate Studies will be named soon. It is anticipated
that providing direct oversight to this office will increase efficiency in the flow
•

•

•

•
•

of paperwork.
The Office of the Provost is evaluating the best use of teaching resources.
The University is offering too many technically under enrolled courses and too
few courses that students need to pursue their degrees. 1-TEL-UNM has
been used for early tracking of student enrollment so that teaching
assignments can be rearranged early in the process to meet student needs.
The reorganization of University College has reached its final stage. Student
advisement and tracking services are now located in the Office of
Undergraduate Studies. University College now houses the BUS program
and General Honors and may eventually house other interdisciplinary units.
Budget reallocation within Academic Affairs has resulted in new library
acquisitions; GAITA salary increases of 7%; opened up new GAITA positions;
established a special fund for faculty promotion salary increases; and devoted
funding for student recruitment and retention.
The process of establishing student outcomes assessment throughout
campus is moving forward. Deans will be receiving specific informatio~ soon.
An academic master plan for Academic Affairs will be dev~lo~ed and will
indicate specific steps to be taken in order to meet the obJect1ves of UNM
2000, the University's master plan.

5. APPROVAL OF SUMMER SESSION 1996 DEGREE CANDIDATES
The Senate approved the summer Session 1996 degree candidates list as
presented.

6· APPROVAL OF CHANGES TO COMMITTEE 1996-97 MEMBE~S.HIP LIST
Changes to the Faculty Senate 1996-97 Committees membership 11st w_er~
approved by the Senate. These are changes and additions to the preliminary
3
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listing approved at the April 9 meeting of the Senate.

7. FORM C FROM THE CURRICULA COMMITTEE
The curricula request for a new Associate of Arts degree in School Health
Promotion from the HPPELP at the Gallup branch was tabled until the October 8
Senate meeting. Representatives from the Gallup branch were not available to
answer questions Senators had regarding the request. Gallup representatives will
be invited to the next Senate meeting to respond to questions.
8. RESEARCH POLICY COMMITTEE REPORT ON THE INTERIM RESEARCH
FRAUD POLICY
Bernard Moret, Chair of the Research Policy Committee presented the revised
Research Fraud Policy for discussion. The Committee reviewed and approved the
revisions which were a result of Federal Agency actions mandating changes to
UNM's Research Fraud Policy as it exists in the Faculty Handbook. A memo from
Robert Bienstock, Associate University Counsel, along with two sets of revisions
were distributed to Senators prior to this meeting. The first set of changes was
required by revisions to the research fraud regulations of the NIH and of the NSF in
1995. The second set of changes was due to a review of the current policy of the
Office of Research Integrity. Discussion ensued and concerns were expressed
that the person accused of fraud be notified early on in the process. A motion,
made by Senator Shama and seconded by Senator Rivera, to amend the last
sentence of Section IV.A.1 on page 5 to delete the period after" . .. as
appropriate", then adding "and inform the accused." was approved by the Senate.
The Senate then voted to approve the policy as amended.

9· CORE CURRICULUM
Charlie Steen, Chair of the Core Curriculum Task Force, led a discussion on the
status of the development of a core curriculum for UNM. The previous approach
taken by the committee to establish core courses has become a very confused
process. The core curriculum document prepared by the committee has brought
forth many recommendations and numerous suggestions. Some departments have
not been able to define their core courses. Other departments want-too many core
courses. As an alternative Chair Steen, at the suggestion of Provost Gordon, is
requesting each department to identify a single block of_ courses that rep~esents
the values of their department, and make recommendat1?~s to t_he committee.
Some senators expressed concern at the length of ti~e 1t 1s ta~in~ to de~elop a
core curriculum proposal. It was requested that Chair Steen ~,stnbute his latest
core curriculum notes to the faculty and Faculty Senate. Chair Steen asked that
recommendations and suggestions be communicated directly to him.

10· ANNOUNCEMENTS - SENATE PRESIDENT
Senate President Woodfin made the following announcements:
4
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•

•
•

•
•

•

•

•

Senators are asked to fill out a Preference Sheet indicating their willingness
to serve as representatives to Faculty Senate Standing Committees. Some
committees are still lacking senate representation. The Preference Sheet
distributed at this meeting should be returned to the Office of the University
Secretary as soon as possible.
Faculty interested in serving on a task force which will review the role of parttime faculty to determine their representation, resources, and benefits should
contact Senate President Woodfin.
A task force is being developed to form a revised method for the evaluation of
administrators. Interested faculty should contact Senate President Beulah
Woodfin.
The development of a faculty dispute resolutions process will be addressed by
the Senate this year.
Finalists for the Associate Dean of Graduate Studies will be interviewed on
September 18, 1996.
One more faculty volunteer is needed to serve on the task force which will
assist the University Secretary in coordinating the updating all sections,
except section B, of the Faculty Handbook. Section B, Conditions of
Employment, is being updated by the Academic Freedom and Tenure
Committee. Interested faculty should contact the University Secretary.
A general faculty meeting will be held on Tuesday, September 24 at 3:30
p.m., in the Kiva for discussion of the constitutional amendment, proposed by
the Committee on Governance, regarding the definition of voting faculty. A
mail ballot to all voting faculty will follow soon after the meeting.
The Regents of the University of Minnesota have passed drastic changes to
the tenure policy for faculty, without regard to faculty input. The American
Association of University Professors is following this issue closely.

11. NEW BUSINESS

Senator Yazawa inquired whether President Peck has been invited to attend ~uture
Faculty Senate meetings. Senate President Woodfin said the Senate Operations
has extended an invitation to President Peck. She will follow up for a response.

12, ADJOURNMENT
The meeting adjourned at 5:05 p.m.

~~

Respectfully submitted by:

'f/J
!);~j tt ltli)) ci ~0
Man A.

Vivian Valencia
University Secretary

Ulibarri
Administrative Assistant
Office of the University Secretary
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The University of New Mexico
University Counsel
Scholes Hall 152
Albuquerque, NM 87131-0056
Telephone (SOS) 277-5035
FAX (505) 277-4154

TO:

Faculty Senate

FROM:

Robert E. Bienstock, Associate University Counse~

RE:

Revisions to Research Fraud Policy

DATE:

September 3, 1996

Federal agency actions have mandated changes to UNM's Research Fraud
Policy, which is published in the Faculty Handbook at page D-12. The first set
of changes was required by revisions to the research fraud regulations of the
NIH and of the NSF in 1995. The second set of changes was triggered by a
review of our current policy by the Office of Research Integrity. A few changes
were also made to improve clarity, logic, and consistency. The proposed
revised policy has been reviewed and approved by the Faculty Research Policy
Committee and this office. A copy is attached, along with copies of the federal
regulations and the ORI review. The revisions that were made to the Policy are
explained in detail below, with the changes due to the ORI's comments
specifically noted as such.
Section I. In the final paragraph of the Introduction to the Policy, we have
~dded language requested by the ORI to the effect that the Policy applies to all

individuals involved in a research project.
Section II. The ORI requested that we expand the definition of research fraud
to include "proposing, conducting, and reporting of sponsored and

unsponsored research."
Section 111.B. We cannot refuse to act upon charges of research fraud
whenever the person who reports it does not fully identify him or herself. First,
as. a matter of policy, if any UNM official were to receive anonym~us but solid
evidence of research fraud it would be incumbent upon that official to pursue
it. The official would be ~bliged both on behalf of the institution in order to
determine if research fraud had occurred, and on behalf of the accused to
Provide an opportunity to clear his or her name. Second, the follow-up is
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Memorandum to Faculty Senate
September 3, 1996
Page No. 2
required by both the NIH and NSF regulations. The NIH regulations require us
to take "immediat e and appropriate action as soon as misconduct . . . is
suspected or alleged," 42 CFR § 50.103(c)(3), and require us to "protectU, to the
maximum extent possible, the privacy of those who in good faith report
apparent misconduct," 42 CFR § 50.103(d)(2). The NSF regulations similarly
rely on us to "initiate an inquiry into any suspected or alleged misconduct," 42
CFR § 689.3(a)(l).
Section 111.C. The NSF regulations define as "misconduct" "retaliation of any
kind against a person who reported or provided information about suspected or
alleged misconduct and who has not acted in bad faith." 45 CFR § 689.l(a)(2).
Thus, we can take action against someone who reports information only if the
information was reported in bad faith. We have revised the sentence about
"persons making intentionally dishonest, malicious, or irresponsible
allegations." The bad faith rule clearly permits action against persons making
intentionally dishonest or malicious allegations. It is less clear with respect to
people making irresponsible allegations, even if the "intentionally" modifies
"irresponsible." Due to this, we have incorporated the regulations' bad faith
standard into our Policy. Note the "intentionally dishonest, malicious, or
irresponsible" standard has been changed throughout our Policy, in Sections

IV.B.3, IV.C.8, and IV.D.3.
Section 111.D. At the request of the ORI, we have changed "faculty members,
staff, and students" to "members of the University community.»
Section IV.A.1. Here, and throughout the document, we have updated the
titles of Vice President for Research or Director of the Medical Center to
Associate Provost for Research or Vice President for Health Sciences.

The last paragraph of Section IV.A. l was added to discuss allegations of
research fraud involving threats to health and safety. In response to the ORI,
we added, "if the research was funded by the NIH or by the PHS, [we] shall
notify the sponsoring agency."
Section IV.B.1. In response to the ORI, we have inserte~ in S~cti?n IV.B. l ~e
same language as we used in the section for formal mvestigations (Section
IV.C.1): "Committee members should be selected on the basis of relevant

research background and experience," etc.
Section IV B 2 Th
a gap between the two possible fmdings of the
. . .
ere was
b
"
d
Inquuy· c
·tt .
" run· a facia responsible and have su stance an
omm1 ee.
p
'bl th t th
"irresponsible trivial or clearly insubstantial." It was poss1 e
a
e
Committee c~uld fmd that the allegations neither had substance nor were
clearly insubstantial. The word "clearly" was deleted to help close that gap.
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~ect~on. IV.B.3. At the request of the ORI, we added, "If the period [of the
mquuy mto the research fraud allegation] is extended, the record of the inquiry
shall include documentation of the reasons for extending beyond the sixty day
period."
Section IV.B.4. The NIH rules require the accused person to be given a copy of
the inquiry report regardless of its conclusions, and to be given an opportunity
to add his or her comments to the report. 42 CFR § 50.103(d)(l).

The same section also specifies that the content of the report must include (1) a
summary of the evidence reviewed, (2) a summary of relevant interviews, and
(3) the conclusions of the inquiry. This requirement has been incorporated into
our Policy.
Section IV.C. l. A gap was caused by the requirement that the investigation go
forward only if the Inquiry Committee vote is unanimous--what if the
Committee could not make a unanimous decision? We would be remiss and
possibly inconsistent with the regulations if a majority of the Committee found
the allegations worth investigating, and we did not do so. It would also taint
the accused person's reputation, with no opportunity for vindication. For these
reasons, the requirement of unanimity was eliminated in Section IV.C.1.

This section requires an Inquiry Committee composed of five tenured UNM
faculty members with relevant research backgrounds and experience. Given
the increasingly specialized nature of research, this may be impossible.
Accordingly, a provision has been added allowing for off-campus Committee
members when appropriate. The approval for off-campus Committee members
was placed with the Associate Provost for Research or Vice President for Health
Sciences, as appropriate.
The penultimate sentence in this section concerns notifying a sponsoring
agency of UNM's decision to commence an investigation. At the request of the
ORI, we have added the words "prior to commencing the investigation• at the
end of that sentence.
The NIH requires that the investigation begin within thirty (30) ~ays after ~e
conclusion of the inquiry. 42 CFR § S0.103(d)(7). We have mcluded this
requirement at the end of this section.
Section IV.C.S. The NIH regulations set specific rules for witness interviews.
They require that "complete summaries of these inte~ews sho':1ld be prepared,
provided to the interviewed party for comment or revision, and mcluded as part
of the investigatory file." 42 CFR § S0.103(d)(7). We defmed the scope of

ZS
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verbatim transcripts as being for hearings and witness interviews. While this
will be quite expensive, it would provide valuable record keeping and data. On
~~ other hand, we did not provide for transcripts of document delivery, site
visits, and tests, as these do not seem useful, nor for deliberations as to which
confidentiality is important.
'

Sections IV.C.6 and IV.C.8. We want to give the Committee the right to make
revisions to its findings based upon the accused's comments. Ditto for the
comments of the accuser in subsection 8.
Section IV.C.9. At the request of the ORI, we have revised this section on the
duration of the investigation to read as follows:

The investigation shall be completed within 180 days. If the research
was sponsored by the PHS, the investigation shall be completed within
120 days, unless PHS grants an extension pursuant to 42 CFR I
50.104(a){5).
Section IV.D.1. The NSF rules expect that we will send a copy of the final
report to the NSF. 45 CFR § 689.3(b)(4). The NIH requires not only that its
Office of Scientific Integrity (OSI) gets a copy of the report, but also that the
accused and accuser get preliminary copies and an opportunity to make
comments. The accuser need be provided with only portions of the report. 42
CFR § 50.104(a){2). Our Policy has been revised accordingly.
Section IV.D.3. In this section, at the request of the ORI, we added a sentence
at the end to clarify what happens to evidentiary material when the Inquiry
Committee does not find research fraud, as follows: "Such documentation shall
be made available to the sponsor of the research where required by law."
~ection IV.E. The NIH regulations have records retention requirements for
mquiry documentation. They require our rules to mandate a three-year
~etention period after the termination of the inquiry. This is the case especially
if the inquiry does not lead to an investigation. 42 CF~ § 5~.103(d)(6).
Although the NIH regulations require only a three-year retention penod, a five-

year period is more prudent.
Section IV.F and Its Subparts.
.
This section on compliance with federal policies has ~een expanded, m p~
due to the ORI's comments, to include more detail about the reporting

requirements of the federal sponsoring agencies.
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Former Section IV.I.4. We deleted the statement that final
should be appended to the policy (and a cross-reference to it
Policy) because realistically we have no means of regularly
appendix containing all relevant federal regulations.
Not
misleading, but we could be accused of luring researchers into
noncompliance with their sponsored agency rules.

/pmd

cc:

Beulah Woodfin, Faculty Senate President
Bernard Moret, Faculty Research Policy Committee

agency rules
earlier in the
updating an
only is this
unsuspecting
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THE UNIVERSITY OF NEW MEXICO
RESEARCH FRAUD POLICY
Marked-Up Version

I.

INTRODUCTION
Integrity, trust, and respect are important elements in an academic research
environment. Investigators typically conduct research and explain findings and
theories with painstaking diligence, precision, and responsibility.

However, a

growing number of cases involving research fraud threatens to both erode the
public trust and cast doubt on the credibility of a ll researchers.

Because the University of New Mexico as well as the general public and
government are affected by this issue, the University has decided to take steps
to deal with research fraud if it arises and to ensure the credibility and objectivity
of research activities. These steps are, in broad terms, to:
Ensure that ethical standards for research at UNM are clearly understood
and applied.
Promptly inquire into allegations of fraud and, where appropriate, initiate
formal investigations and advise sponsors of action taken.
Ensure that each investigation is properly documented to support findings
and carefully conducted to protect any person whose reputation may
be placed at risk during the process.

1

284
The policy and procedures regarding research fraud are intended to protect the
integrity of the University's research enterprise and not hinder the search for truth
or interfere with academic freedom.

This Policy applies to all individuals who may be involved with a research
project, including, but not limited to, faculty, graduate/undergraduate students,
staff, employees, contractors, visiting scholars, and any other member of the
academic community at the institution who may be involved with a research
project.

II.

DEFINITION

"Research fraud" or "fraud" applies to the proposing, conducting, and reporting
of sponsored and unsponsored research and means: intentional fabrication,
falsification, misrepresentation, theft, or plagiarism concerning research resu lts,
activities, and related documentation; it also means gross carelessness in
conducting research amounting to wanton disregard of truth or objectivity, or
failure to comply or at least attempt to comply with material and relevant
aspects of valid statutory or regulatory requirements governing the research in
question.

Research fraud is not an error in judgment, a misinterpretation of

experimental results, an oversight in attribution, a disagreement with recognized
authorities, a failure in either inductive or deductive reasoning, an error in

2
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planning or carrying out experiments, a calculation mistake, or being wrong or
ignorant.

Ill.

PolicyGENERAL PRINCIPLES

A.

Research fraud cannot be tolerated and will be firmly dealt with when clearly
shown to be present.

B.

Charges of research fraud by persons who do not fully identify themselves shall
not be acted upon. Charges from a properly identified party of research fraud
shall be promptly reviewed and a copy of this Policy shall be made available to

StJ€R the charging party. If health or safety is involved, prompt remedia l action
shall be taken. The charges shall be treated at ascending levels of forma lity to
minimize distraction from normal activities and permit the taking of action
tailored to the authenticity and seriousness of the c harges and the nature and
extent of the m isconduct.

C.

Every effort shall be made to protect the rights and the reputations of everyone
involved, including the individual who in good faith alleges perceived
misconduct as well as the alleged violator(s).

However, persons making

intentionally dishonest, malicious, or irresponsible allegations in bad faith shall be
severely dealt with and may be subject to dismissal as well as criminal and/or
civil legal action.

3
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D.

All faculty members, staff, and students members of the University community
are expected

to

cooperate

with

committees

conducting

inquiries or

investigations. Care will be exercised at all times to ensure confidentiality to the
maximum extent possible and to protect the safety and privacy of persons
involved in the research under inquiry or investigation.

Files involved in an

Inquiry or Formal Investigation shall be kept secure and not retrievable by
personal identifiers, and applicable State and Federal law shall be followed
regarding confidentia lity of personnel records.

IV.

PROCEDURES

A.

Processing Initial Allegations of Research Fraud

1.

An initial report of alleged fraud shall be treated and brought in a confidential
manner to the attention of the faculty member or other person (e.g.,
chairperson, supervisor, director, principal investigator) responsible for the
researcher(s) whose actions are in question. (Accuser may wish to seek counsel
prior to bringing charges.) That faculty member or other person shall, in turn,
make an immediate confidential report of the allegations to the Vice President
for Research or the Director of the Medical Center, Associate Provost for
Research or Vice President for Health SciencesL as appropriate.

The ¥+ce

Fresident for Research or the Director for the Medical Genter Associate Provost
for Researc h or V.ice pres,'d e nt for Health Sciences may at their discretion and as
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they deem appropriate inform the accused of the charges and, if the accuser
consents, of the identity of the accuser. The Vice President for Research or the
Director of the Medical Center acting as appropriate through deans,
chairpersons or directors shall take immediate corrective action if a threat to
health or safety is involved.
If a threat to health or safety is involved, the Associate Provost for Research or
Vice President for Health Sciences, acting as appropriate through deans,
chairpersons or directors, shall take immediate corrective action, and, if the
research was funded by the NIH or by the PHS, shall notify the sponsoring
agency.
2.

The Vice President for Research or the Director of the Medical Genter Associate
Provost for Research or Vice President for Health Sciences shall promptly review
the allegation and prepare an initial finding. (Note: "Finding" as used herein
means a written document containing a full explanation of the facts and the
reasoning which supports a decision of innocence or violation.)

The ¥iee

President for Research or Director of the Medical Center: Associate Provost for
Research or Vice President for Health Sciences may appoint an ad hoc
Committee for this purpose.

Such Committee shall consist of three faculty

members at least two of whom including the chairperson shall be tenured.
Deans, chairpersons, and directors shall be eligible for appointment to such
Committee. Should the allegation be considered frivolous or unfounded by the
.Vice President for Research or the Director of the Medical Genter: Associate

5
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Provost for Research or Vice President for Health Sciences, the person bringing
the charges shall be so informed and appropriate further inquiry made, if
necessary, concerning the accuser's motivation or responsibility.

The lABe

President for Research or Director of the tvtedical Center Associate Provost for
Research or Vice President for Health Sciences shall take disciplinary action
against the accuser if appropriate or recommend administrative sanctions or
criminal or civil legal action to the President.
B.

Inquiry

1.

If from the report and initial finding the Vice President or Director of the Medical
Center Associate Provost for Research or Vice President for Health Sciences
believes that allegations warrant further inquiry, the Vice President for Research
or Director of the Medical Center Associate Provost for Research or Vice
President for Health Sciences shall provide a copy of the finding to the President
and shall appoint an Inquiry Committee of three persons other than persons
previously serving as ad hoc Committee members. At least two Committee
members shall be tenured faculty. One of the tenured faculty members shall
chair the Committee. Committee members should be selected on the basis of
relevant research background and experience.

With the approval of the

Associate Provost for Research or Vice President for Health Sciences, as
appropriate, faculty members from other Universities may be named to the
ommittee if a sufficient number of ualified and neutral NM facul

members

are not available. Care shall be taken to ensure that no Committee member

6
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has a potentia l or actual conflict of interest with the researcher(s) under
investigation or with the accuser.

All Committee meetings shall be held in

confidence in a secure area.

2.

The Inquiry Committee shall promptly review the initial report and finding and
other available information on a preliminary basis. If, based on this preliminary
review, the Committee believes that the Inquiry should be dropped because
the allegations are irresponsible, trivial, or clearly insubstantial, the Committee
shall submit a finding to that effect to the Vice President for Research or tho
Director of the ,tlAedical Center Associate Provost for Research or Vice President
for Health Sciences, as appropriate, and to the President, and the Inquiry shall
be terminated preferably without any notice or publicity whatsoever, except for
action as in A.2. if appropriate. If, however, the Inquiry Committee believes the
allegations are prima facie responsible and have substance, the Committee
shall notify the sponsoring agency if appropriate under the agency's criteria, and
each person accused of fraud shall be advised by the Vice President fOf
Research or the Director of the Medical Center Associate Provost for Research or
Vice President for Health Sciences in writing of (a) the allegations, (b) the identity
of the accuser, (c} the identity of the Committee members, (d} the right to retain
private counsel, and (e} the need to retain all documents, records, tapes, etc.,
relating to the research in q uestion in unaltered condition.

3.

The length of the inquiry shall not exceed sixty days unless prior written approval
for a longer period is obtained from the ¥ice President for Research or the
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Director of the Medical Center Associate Provost for Research or Vice President
for Health Sciences. If the period is extended, the record of the inquiry shall
include documentation of the reasons for exceeding the sixty day period.-A#ef
completion of the inquiry, the Inquiry Committee's finding shall be provided to
the Vice President for Research or the Director of the Medical Center and to the
President. [Note: Similar text inserted in the following section]

If the Inquiry

Committee's finding is that the allegations lack sufficient substance or support to
justify a formal investigation; the individual(s) who reported the alleged fraud
and the accused shall be so notified in writing by the Committee Chairperson.

4.

The Inquiry Rreport shall include (a) a summary of the evidence reviewed, (bl a
summary of relevant interviews, and

(cl

the conclusions of the inquiry. The

accused shall be given an opportunity to add his or her comments to the report
and have those comments distributed with the original. After completion of the
inquiry, the Inquiry Committee's finding shall be provided to the Associate
Provost for Research or Vice President for Health Sciences, the President, the
individual(s) who reported the alleged fraud and to the accused.
5·

All University personnel involved in or contacted in connection w ith the inquiry
shall be informed in writing of the results and shall refrain from making any
comments on the matter whatsoever outside of Committee business unless
authorized in writing by the Committee Chair. If in its finding the Committee also
determines that the charges were dishonest, malicious, or irresponsible;- made in
bad faith, the Vice President for Research or the Director of the Medical GentOf

8
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Associate Provost for Research or Vice President for Health Sciences, or, if
necessary, the President, sha ll take appropriate disciplinary or legal action suc h
as proceedings leading to d ismissal of the person making the charges or referral
of the matter for crimina l or civil legal action.

C.

Formal Investigation

1.

If the Inquiry Committee unanimously recommends in writing to the ¥i6e
President for Research or Director of the Medical Center Associate Provost for
Research or Vice Preside nt for Health Scie nces that a formal investig ation is
warranted, the Vice President for Researc h or the Director of the Medical Genter
Associate Provost for Research or Vic e President for Health Sciences, as
appropria te, sha ll appoint in consultation with the University President an
Investigatio n Committee of five tenured faculty members including the
chairperson. No person sha ll be appointed to the Investigation Committee who
was ineligib le for or w ho served on the Inquiry Committee. or who has any
potential or a ctual conflict of interest w ith the persons under investigation or with
the accuser. Committee members should be selected on the basis of relevant
research background and experience.

With the approval of the Associate

Provost for Research or Vice President for Health Scienc es, as appropriate,
faculty members from other Universities may be named to the Committee, if a
sufficient number o f q ua lified and neutra l UNM faculty m embers are not
available.

If req uired by sponsoring agency regulations, the University shall

notify the a g ency of its decision to commence a n investigation prior to

9
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commencing the investigation. The investigation shall begin w ithin thirty (30)
days after the conclusion of the inquiry.
2.

Each researcher under investigation shall be apprised of the allegations in
writing, of the identity of the members of the Investigation Committee, and of
the right to retain private legal counsel. The accused person(s) as a whole and
the accuser(s) as a whole shall each have the right to challenge the
appointment of one member. Such challenge shall be made in writing to the
chairperson within 10 days of notification of the identity of members.

Upon

receipt of the challenge the chairperson shall promptly appoint another
member to replace the challenged member and notify all parties of the
member's identity. Further, the accused person or persons as a whole shall be
accorded the right to select one person not under investigation having
technical expertise to assist the Committee. Such person shall be appointed to
the Committee sa--as a non-voting member and shall be subject to a ll rules
adopted

by

the

Investigation

Committee

including

requirements

for

confidentiality.
3.

During the investigation University legal counsel shall be available to the
Committee tor consultation.

Information concerning the research under

investigation such as laboratory notebooks and related records of research
activities, topical, technica l, and summary reports, drafts of unpublished
manuscripts and related data and materials shall be made available as
requested by the Committee.

10
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4.

The Committee shall hold a ll meetings in confidence unless open meetings are
approved in writing by the President. The Committee from time to time shall
inform each accused person under investigation of its general progress.
Accused persons under investigation shall be treated as innocent of the c harges
at all times until and unless duly found to be in violation. Accused persons shall
be afforded the opportunity to respond to the charges and to questions posed
by the Committee and to provide additional information or explanations
voluntarily. In response to a request by the accused or on the Committee's own
initiative, it sha ll be a matter of the Committee's sole discretion subject to written
approval of the President as to whether and how the accused and accuser
should confront each other, or the case should be publicized. Factors to be
considered in recommending such disclosure, confrontation, or publication shall
include a) the behavior and actions of the accused and accuser, b) regulatory
requirements of the sponsoring agency or contractual provisions governing the
research, c) whether in view of the nature of the case the proposed action
would enhance impartiality, objectivity, and fairness in the manner of
conducting the Committee's proceedings and in reaching a just decision, and
d) the relationship of the University's investigative efforts to criminal or civil court
proceedings or to investigative efforts by the sponsor.

5.

The Committee may in its discretion for itself or on behalf of the accused or
accuser require delivery of documents, interview witnesses, take depositions or
signed statements of witnesses, obtain evidence, visit sites,

11
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The Committee may also and hold hearings.:. GAG The Committee shall maintain
a verbatim written record of all proceedings witness interviews and hearings.
Each witness shall be provided transcripts of the interview for comment or
revision. which shall become part of the investigatory file.

Courtroom

proceedings may be followed at the discretion of the Committee. The President
or President's designee may be present at any proceeding or meeting of the
Committee.
6.

A finding that a person has committed research fraud shall require a unanimous
vote of the Investigation Committee. The accused person shall have fourteen
days to provide comments on the finding to the Committee. The Committee
may change its vote, report and/or finding based upon the comments.

7.

If a unanimous vote of the Committee for a finding of research fraud is not
obtained, then the person under investigation is innocent of research fraud.

8.

The Committee may also recommend separately or with the above findings
that, because in its unanimous opinion the allegations of fraud appear to

ae

malicious, intentionally dishonest, or irresponsible have been made in bad faith,
a further investigation of the accuser should be initiated.

Alternatively, the

Committee may actually find by unanimous vote that the allegations of
research fraud were malicious, intentionally dishonest, or irresponsible made in
bad faith.

In such instance, the accuser shall have fourteen days to provide

written comments thereon to the Committee. The Committee may change ifs
vote, report and/or finding based upon the comments.
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9.

The findings in 6, 7, or 8 above and the comments of the accused and/or
accuser as applicable shall be included in a final written report of the
Committee signed by all voting members which shall be submitted to the
President. The investigation shall be completed within 180 days. If the research
was sponsored by the PHS, the investigation shall be completed within 120 days,
unless PHS grants an extension pursuant to 42 C.F.R. § 50.104(al(5).

D.

Action Following Investigation

1.

The final report shall be made available to the sponsoring agency, the person(s}
accused, and appropriate portions to the accuser(sl.

2.

If the Committee finds research fraud, the University shall take the following
actions as required or appropriate:
a)

Notify the sponsoring agency of the findings;

b)

Take steps to withdraw, retract, modify, or explain all pending and

previously published abstracts and papers related to the fraudulent research
and to alert publishers, organizations, and the public to the affected research;
c)

Take

or

initiate

appropriate

disciplinary

action

(e.g.,

dismissal

proceedings) as well as administrative, criminal, or civil legal action concerning
the persons found to have committed research fraud; and
d)

Take any other steps deemed appropriate to accomplish justice and

preserve the integrity of the University and the credibility of the Sponsors
program.

13
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If the Committee does not find research fraud, efforts will be undertaken to the
extent possib le and appropriate by the University to fu lly protect, restore, or
maintain the credibility of the research project, research results, and the
reputation of the accused, the sponsor, and others who were involved in the
investigation

or

deleteriously

affected

thereby.

Evidentiary

material,

documents, etc., shall be disposed of in accordance with University Counsel's
advice. Such documentation shall be made available to the sponsor of the
research where req uired by law.

~.4.

If the Committee further finds that a party's allegations were malicious,
intentionally dishonest, or irresponsible made in bad faith, steps shall be taken by
the University to further investigate the party and take appropriate disciplinary or
legal action.

If such party is not associated with the University, a ppropriate

organizations or authorities shall be notified and administrative or legal action
considered.
4.5..

The Board of Regents in the pursuit of justice and fairness may, in its sole
discretion, fu lly or partially reimburse the accused and/ or the accuser for legal
fees in cases of unusual hardship.

f.

Document Retention

All documentation of an inquiry that does not lead to an investigation shall be
maintained for at least three 3

ears after the conclusion of the in ui
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shall be provided to the sponsoring agency upon request if required by the
agency's regulations.

All documentation of the investigation shall

be

maintained for five (51 years after the end of the investigation.

fJ

Compliance with Federal Policies

Faculty members or others who are on the staff of the Veterans Administration
Medical Center or who perform clinical, medical, or other specialized research
under the aegis of UNM must also comply with federal policies and guidelines
which govern such work.

See paragraph

l=I! below. The Committees shall

cooperate with the University in meeting various federal agency reportin
requirements regarding their inquiries or investigations. In particular,

the National

Science Foundation [see 45 CFR Part 689.3(bll and the OS!/NIH/PHS

[see 42 CFR

Part 50.103, 104] have special reporting requirements.

1.

Faculty members or others who are on the staff of the Veterans Administrafjon
Medical Center or who perform clinical, medical, or other specialized research
under the aegis of UNM must also comply with federal policies and guidelines
which

overn such work.

See

The

ommi tees

hal

cooperate with the University in meeting various federal agency repo inq
re

689.3(bl] and the OSI/NIH/PHS [see 42 C.F.R. Part
with.
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50.103, 104] shall be complied
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2.

If the Research was funded by the PHS, the following notification requirements
shall be followed:

2.a.

ORI shall be notified at any stage of the inquiry or investigation if any of the
following conditions exist:
an immediate health hazard involved
an immediate need to protect federal funds or equipment
an immediate need to protect the interests of the person(sl making the
allegations or of the individual(sl who is/are the subject of the allegations as well
as his/her co-investigators and associates, if any
a probability that the alleged incident is going to be reported publicly
a reasonable indication of possible criminal violation (notification of ORI
within 24 hours).

2.b.

If an inquiry or investigation is terminated without completing all required steps,
a report of such planned termination, including a description of reasons, shall be
made to ORI.

2,c.

ORI shall be promptly advised of any developments during the course of an
investi ation that disclose facts that ma

affect current or

otential DHH

funding for individual(s) under investigation or that the PHS needs to know to
ensure a

ro riate use of Federal funds and otherwise

interest.

16
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2.d.

The fina l report to ORI sha ll describe the policies a nd procedures under which
the investigation was conducted, how and from whom information was
obtained re levant to the investigation, the findings, and the basis for the findings,
and include the actual text or an accurate summary of the views of any
individual(sl found to have engaged in misconduct, as w ell as a description of
any sanctio ns taken by the institution.

G.f

Distribution of this Document

Present faculty and staff shall be given copies of this document as soon as
possible.

New facu lty a nd staff shall be issued a c opy a t the time of initial

employment, and dissemination shall be made to students in an a ppropriate
manner.
H.G

C ontinuing Review of Policy

These University policies a nd procedures rela ting to ethical cond uct of research
and investigation of a llegations of fraud shall be under continuing review and
modified in light of the experience gained. Suggestions for revision should be
sent to the Research Polic y Committee.

L.H

Treatment of Federal Agencies' Final Rules

1.

As federa l agencies issue their ow n final ru les on misconduct in science which
set forth the duties a nd responsibilities of their awardee and applicant
institutions, such fina l rules will govern where a pplicable.
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2.

It shall be the responsibility of each individual, unit, or group involved in applying
for, receiving, or working under, grants or contracts with the federal agency to
be familiar with that agency's final rule on misconduct in science.

3.

Questions concerning the applicability of a federa l agency fina l ru le in matters
of misconduct in science shall be referred to the University Counsel for
resolution.

4.

Agency final rules shall be appended hereto for record purposes.

Previous version approved by UNM Faculty Senate, April 11 , 1989; Ratified by the
Regents, November 14, 1989

/pmd

18

30 1
THE UNIVERSITY OF NEW MEXICO
RESEARCH FRAUD POLICY
INTRODUCTION
Integrity, trust, and respect are important elements in an academic
research environment.

Investigators typically conduct research and

explain findings and theories with painstaking d iligence, precision, and
responsibility. However, a growing number of cases involving research
fraud threatens both to erode the public trust and to cast doubt on the
credibility of all researchers.

Because the University of New Mexico as well as the general public and
government are affected by this issue, the University has decided to take
steps to deal with research fraud if it arises and to ensure the c redibility
and objectivity of research activities. These steps are, in broad terms, to:

Ensure that ethical standards for research at UNM
are clearly understood and applied.

Promptly inquire into allegations of fraud and, where
appropriate, initiate formal investigations and advise
sponsors of action taken.

Ensure that each investigation is properly
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documented to support findings and carefully
conducted to protect any person whose
reputation may be placed at risk during the process.

The policy and procedures regarding research fraud are intended to
protect the integrity of the University's research enterprise and not hinder
the search for truth or interfere with academic freedom.

This Policy applies to all individuals who may be involved with a research
project, including, but not limited to, faculty, graduate/undergraduate
students, staff, employees, contractors, visiting scholars, and any other
member of the academic community at the institution who may be
involved with a research project.

II.

DEFINITION
"Research fraud" or "fraud" applies to the proposing, conducting and
reporting

of

sponsored

and

unsponsored

research

and

means:

intentional fabrication, falsification, misrepresentation, theft, or plagiarism
concerning research activities, results, and related documentation; it also
means gross carelessness in conducting research amounting to wanton
disregard of truth or objectivity, or failure to comply or at least attempt to
comply with material and relevant aspects of valid statutory or regulatory
requirements governing the research in question. "Research fraud" is not

2
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an error in judgment, a misinterpretation of experimental results, an
oversight in attribution, a disagreement with recognized authorities, a
failure in either inductive or deductive reasoning, an error in planning or
carrying out experiments, a calculation mistake, or being wrong or
ignorant.

Ill.

GENERAL PRINCIPLES

Ill.A.

Research fraud cannot be tolerated and will be firmly dealt with when
clearly shown to be present.

111.B.

Charges of research fraud shall be promptly reviewed and a copy of this
Policy shall be made available to the charging party. If health or safety is
involved, prompt remedial action shall be taken. The charges sha ll be
treated at ascending levels of formality to minimize distraction from
normal activities and permit the taking of action tailored to the
authenticity and seriousness of the charges and the nature and extent of
the misconduct.

111.C.

Every effort shall be made to protect the rights and the reputations of
everyone involved, including the individual who in good faith a lleges
perceived misconduct as well as the alleged violator(s).

3
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persons making a llegations in bad faith shall be severely dealt with and
may be subject to dismissal as well as criminal and/ or civil legal action.

111.D.

All members of the University community are expected to cooperate with
committees conducting inquiries or investigations. Care will be exercised
at all times to ensure confidentiality to the maximum extent possible and
to protect the safety and privacy of persons involved in the research
under inquiry or investigation.

Files involved in an Inquiry or Formal

Investigation shall be kept secure and not retrievable by personal
identifiers, and applicable State and Federal law shall be followed
regarding confidentia lity of personnel records.

IV.

PROCEDURES

IV.A.

Processing Initial Allegations of Research Fraud

IV.A.1.

An initial report of alleged fraud shall be treated and brought in a
confidential manner to the attention of the faculty member or other
irperson supervisor, director, principal investigator)
person (e.g., c ha
,
responsible for the researcher(s} whose actions are in question. (Accuser
may w ish to seek counsel prior to bringing charges.) That faculty member
· turn make an immediate confidential report of
or other person sha II, in
,

4
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the allegations to the Associate Provost for Researc h or Vice President for
Health Sciences, as appropriate.

If a threat to health or safety is involved, the Associate Provost for
Research or Vice President for Health Sciences, acting as appropriate
through deans, chairpersons or directors, shall take immediate corrective
action, and, if the research was funded by the NIH or by the PHS, shall
notify the sponsoring agency.

IV.A.2.

The Associate Provost for Research or Vice President for Health Sciences
shall promptly review the allegation and prepare an initial finding. (Note:
"Finding" as used herein means a written document containing a full
explanation of the facts and the reasoning which supports a decision of
innocence or violation.}

The Associate Provost for Research or Vice

President for Health Sciences may appoint an ad hoc Committee for this
purpose. Such Committee shall consist of three faculty members at least
two of whom including the c hairperson shall be tenured.

Deans,

chairpersons, and directors shall be eligible for appointment to such
Committee. Should the allegation be considered frivolous or unfounded
by the Associate Provost for Research or Vice President for Health
Sciences, the person bringing the charge shall be so informed and
appropriate further inquiry made, if necessary, concerning the accuser's
motivation or responsibility. The Associate Provost for Research or Vice

5
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President for Health Sciences shall take disciplinary action against the
accuser if appropriate or recommend administrative sanctions or criminal
or civil legal action to the President.

IV.B.

Inquiry

IV.B.1.

If from the report a nd initial finding the Associate Provost for Research or
Vice President for Health Sciences believes that a llegations warrant
further inquiry, the Associate Provost for Researc h or Vice President for
Health Sciences sha ll provide a copy of the finding to the President and
shall appoint an Inquiry Committee of three persons other than persons
previo usly serving as ad hoc Committee mem bers.
Committee members shall be tenured faculty.
faculty members shall chair the Committee.

At least two

One of the tenured
Committee members

should be selected on the basis of relevant research background and
experience. With the approval of the Associate Provost for Research or
Vice President for Health Sciences, as appropriate, faculty members from
other Universities may be named to the Committee, if a sufficient number
of q ua lified and neutral UNM faculty members are not available. Care
shall be taken to ensure that no Committee member has a potential or
actua l conflict of interest with the researc her(s) under investigation or with
the accuser. All Com mittee meetings shall be held in confidence in a
secure area.

6
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IV.B.2.

The Inquiry Committee shall promptly review the initial report and finding
and other available information on a preliminary basis. If, based on this
preliminary review, the Committee believes that the Inquiry should be
dropped because the allegations are irresponsible, trivial, or insubstantial,
the Committee shall submit a finding to that effect to the Associate
Provost for Research or Vice President for Health Sciences, as appropriate,
and to the President, and the Inquiry shall be terminated preferably
without any notice or publicity whatsoever, except for action as in A.2. if
appropriate. If, however, the Inquiry Committee believes the allegations
are prima facie responsible and have substance, the Committee shall
notify the sponsoring agency if appropriate under the agency's criteria,
and each person accused of fraud shall be advised by the Associate
Provost for Research or Vice President for Health Sciences in writing of (a)
the allegations, (b) the identity of the accuser, (c) the identity of the
Committee members, (d) the right to retain private counsel, and (e) the
need to retain all documents, records, tapes, etc., relating to the
research in question in unaltered condition.

IV.B.3.

The length of the inquiry shall not exceed sixty days unless prior written
approval for a longer period is obtained from the Associate Provost for
Research or Vice President for Health Sciences. If the period is extended,

7
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the record of the inquiry shall include documentation of the reasons for
exceeding the sixty day period.

IV.B.4.

The Inquiry Report shall include (a) a summary of the evidence reviewed,
(b) a summary of relevant interviews, and (c ) the conclusions of the
inquiry. The accused shall be given an opportunity to add his or her
comments to the report, and have those comments distributed with the
origina l. After completion of the inquiry, the Inq uiry Committee's finding
shall be provided to the Associate Provost for Research or Vice President
for Health Sciences, the President, the individual(s) who reported the
a lleged fraud and to the accused.

IV.B.5.

All University personnel involved in or contacted in connection with the
inquiry shall be informed in writing of the results and shall refrain from
making any comments on the matter whatsoever outside of Committee
business unless authorized in writing by the Committee Chair.

If in its

finding the Committee also determines that the c harges were made in
bad faith, the Associate Provost for Research or Vice President for Health
Sciences, or, if necessary, the President. shall take appropriate disciplinary
or legal action such as proceedings leading to dismissal of the person
making the charges or referral of the matter for criminal or civil legal
action.

8
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IV.C.

Formal Investigation

IV.C.1.

If the Inquiry Committee recommends in writing to the Associate Provost
for Research or Vice President for Health Sciences that a formal
investigation is warranted, the Associate Provost for Research or Vice
President for Health Sciences, as appropriate, shall appoint in consultation
with the University President an Investigation Committee of five tenured
faculty members including the chairperson.

No person shall be

appointed to the Investigation Committee who was ineligible for or who
served on the Inquiry Committee, or who has any potential or actual
conflic t of interest with the persons under investigation or with the
accuser.

Committee members should be selected on the basis of

relevant research background and experience. With the approval of the
Associate Provost for Research or Vice President for Health Sciences, as
appropriate, faculty members from other Universities may be named to
the Committee, if a sufficient number of qualified and neutral UNM
faculty members are not available. If required by sponsoring agency
regulations, the University shall notify the agency of its decision to
commence an investigation prior to commencing the investigation. The
investigation shall begin within thirty (30) days after the conclusion of the
inquiry.

9
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IV.C.2.

Each researcher under investigation shall be apprised of the a llegations in
writing , of the identity of the members of the Investigation Committee,
and of the right to retain private legal counsel. The accused person(s) as
a whole and the accuser(s) as a whole shall each have the right to
challenge the appointment of one member. Such challenge shall be
made in writing to the chairperson within ten days of notification of the
identity of members. Upon receipt of the challenge the chairperson shall
promptly appoint another member to replace the challenged member
and notify all parties of the member's identity.

Further, the accused

person or persons as a whole shall be accorded the right to select one
person not under investigation having technical expertise to assist the
Committee. Such person shall be appointed to the Committee as a nonvoting member and shall be subject to all rules adopted by the
Investigation Committee including requirements for confidentiality.

IV.C.3.

During the investigation University legal counsel shall be available to the
Committee for consultation. Information concerning the research under
investigation such as laboratory notebooks a nd related records of
research activities, topical, technical, and summary reports, drafts of
unpublished manuscripts and related data and materials shall be made
available as requested by the Committee.

10
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IV.C.4.

The Committee shall hold all meetings in confidence unless open
meetings are approved in writing by the President. The Committee from
time to time shall inform each accused person under investigation of its
general progress. Accused persons under investigation shall be treated
as innocent of the charges at a ll times until and unless duly found to be in
violation. Accused persons shall be afforded the opportunity to respond
to the charges and to questions posed by the Committee and to provide
additional information or explanations voluntarily.

In response to a

request by the accused or on the Committee's own initiative, it shall be a
matter of the Committee's sole discretion subject to written approval of
the President as to whether and how the accused and accuser should
confront each other, or the case should be publicized.
considered

in

recommending

such

disclosure,

Factors to be

confrontation,

or

publication shall include a) the behavior and actions of the accused and
accuser, b) regu latory requirements of the sponsoring agency or
contractual provisions governing the research, c ) whether in view of the
nature of the case the proposed action would enhance impartia lity,
objectivity, and fairness in the manner of conducting the Committee's
proceedings and in reaching a just decision, and d) the relationship of
the University's investigative efforts by the sponsor.

1v.c.s.

The Committee may in its discretion for itself or on behalf of the accused
·re del'ivery of documents, interview witnesses, take
or accuser req U1
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depositions or signed statements of witnesses, obtain evidence, visit sites,
replicate tests, and hold hearings.

The Committee shall maintain a

verbatim written record of all witness interviews and hearings.

Each

witness shall be provided transcripts of the interview for comment or
revision, which shall become part of the investigatory file.

Courtroom

proceedings may be followed at the discretion of the Committee. The
President or President' s designee may be present at any proceeding or
meeting of the Committee.

IV.C.6.

A finding that a person has committed research fraud shall require a
unanimous vote of the Investigation Committee. The accused person
shall have fourteen days to provide comments on the finding to the
Committee. The Committee may change its vote, report and/ or finding
based upon the comments.

IV.C.7.

If a unanimous vote of the Committee for a finding of research fraud is
not obtained, then the person under investigation is innocent of research
fraud.

1v.c.a.

The Committee may also recommend separately or with the above
findings that, because in its unanimous opinion the allegations of fraud
ma de in bad faith a further investigation of the
b
appear t o h ave een
'
accuser should be initiated. Alternatively, the Committee may actually
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31Jfind by unanimous vote that the a llegations of research fraud were made
in bad faith. In such instance, the accuser shall have fourteen days to
provide written comments thereon to the Committee. The Committee
may change its vote, report and/or finding based upon the comments.

IV.C.9.

The findings in 6, 7, or 8 above a nd the comments of the accused and/ or
accuser as applicable shall be included in a final written report of the
Committee signed by all voting members which shall be submitted to the
President. The investigation shall be completed within 180 days. If the
research was sponsored by the PHS, the investigation shall be completed
within 120 days, unless PHS grants an extension pursuant to 42 C.F.R. §

50. 104 (a)( 5).

IV.D.

Action Following Investigation

IV.D.1.

The final report shall be made available to the sponsoring agency, the
person (s) accused, and appropriate portions to the accuser(s).

IV.D.2.

If the Committee finds research fraud, the University shall take the
following actions as required or appropriate:

IV.D.2.a.

Notify the sponsoring agency of the findings;
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IV.D.2.b.

Take steps to withdraw, retract, modify, or explain all pending and
previously published abstracts and papers related to the fraudulent
research and to a lert publishers, organizations, and the public to the
affected research;

IV.D.2.c.

Take

or

initiate

appropriate

disciplinary

act·1on

(e.g.,

d.1sm1ssa
· I

proceedings) as well as administrative, a criminal, or civil legal action
concerning the persons found to have committed research fraud; and

IV.D.2.d.

Take any other steps deemed appropriate to accomplish justice and
preserve the integrity of the University and the credibility of the Sponsor's
program.

IV.D.3.

If the Committee does not find research fraud, efforts will be undertaken
to the extent possible and appropriate by the University to fully protect,
restore, or maintain the credibility of the research project, research results,
and the reputation of the accused, the sponsor, and others who were
involved

in

the

investigation

or

deleteriously

affected

thereby.

Evidentiary material, documents, etc., shall be maintained or disposed of
in accordance with University Counsel's advice. Such documentation
shall be made available to the sponsor of the research where required by
law.
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IV.D.4.

If the Committee further finds that a party's allegations were made in bad
faith, steps shall be taken by the University to further investigate the party
and take appropriate disciplinary or legal action.

If such party is not

associated with the University, appropriate organizations or authorities
shall be notified and administrative or legal action considered.

IV.D.5.

The Board of Regents in the pursuit of justice and fairness may, in its sole
discretion, fully or partially reimburse the accused and/or the accuser for
legal fees in cases of unusual hardship.

IV.E.

Document Retention

All documentation of an inquiry that does not lead to an investigation
shall be maintained for at least three (3) years after the conclusion of the
inquiry, and shall be provided to the sponsoring agency upon request if
required by the agency's regulations.

All documentation of an

investigation shall be maintained for five (5) years after the end of the
investigation.

IV.F.

IV.F.1.

Compliance With Federal Policies

b

thers who are on the staff of the Veterans

Faculty mem ers or o
· ·
· M d' I Center or who perform clinical, medical, or other
Adm1nistratton e 1ca
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specialized research under the aegis of UNM must a lso comply with
federa l policies and guidelines w hich govern such work. See paragraph I
below. The Committees shall cooperate with the University in meeting
various federal agency reporting requirements regarding their inquiries or
investigations.

In particular, the special reporting req uirements of the

National Science Foundation [see 45 C.F.R. Part 689.3(b)] and the
OSI/NIH/PHS [see 42 C.F.R. Part 50. 103, 104] shall be complied with.

IV.F.2.

If the Research w as funded by the PHS, the following notification
requirements shall be followed:

IV.F.2.a.

ORI shall be notified at any stage of the inquiry or investigation if any of
the following conditions exist:
an immedia te health hazard involved
an immediate need to protect federa l funds or equipment
an immediate need to protect the interests of the person (s)
making the a llegations or of the individ ua l(s) who is/ are the
subject of the allegations as well as his/her co-investigators
and associates, if any
a probability that the a lleged incident is going to be reported
publicly
a reasonable indication of possible crimina l violation (notification
of ORI within 24 hours).
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IV.F.2.b.

If an inquiry or investigation is terminated without completing all required
steps, a report of such planned termination, including a description of
reasons, shall be made to ORI.

IV.F.2.c.

ORI shall be promptly advised of any developments during the course of
an investigation that disclose facts that may affect current or potential
DHHS funding for individual (s) under investigation or that the PHS needs to
know to ensure appropriate use of Federal funds and otherwise protect
the p ub lic interest.

IV.F.2.d.

The final report to ORI shall describe the policies and procedures under
which the investigation was conducted, how and from w hom information
was obtained relevant to the investigation, the findings, and the basis for
the findings, and include the actual text or an accurate summary of the
views of any individual(s) found to have engaged in misconduct, as well
as a description of any sanctions taken by the institution.

IV.G.

Distribution of this Document
Present faculty and staff shall be given copies of this document as soon
as possible. New faculty and staff shall be issued a copy at the time of
initial employment, and dissemination shall be made to stud ents in an
appropriate manner.

17

IV.H.

Continuing Review of Policy
These University policies and procedures relating to ethical cond uct of
research and investigation of allegations of fraud shall be under
continuing review and modified in light of the experience gained.
Suggestions for revision should be sent to the Research Policy Committee.

IV.I.

Treatment of Federal Agencies' Final Rules

IV.1.1.

As federal agencies issue their own final rules on misconduct in science
which set forth the duties and responsibilities of their awardee and
applicant institutions, such fina l rules will govern where applicable.

IV.1.2.

It shall be the responsibility of each individual, unit, or group involved in
applying for, receiving, or working under, grants or contracts with the
federal agency to be familiar with that agency's final rule on misconduct
in science.

IV.1.3.

Questions concerning the applicability of a federal agency fina l rule in
matters of misconduct in science shall be referred to the University
Counsel for resolution.
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